Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...
Researchers unveil the first 48-channel high-throughput SPR platform, enabling primary screening of large molecular libraries with high-resolution binding data, 12-fold higher throughput, and minimal ...
Cells constantly monitor and recycle their proteins through a tightly regulated waste-disposal system. Proteins that are no ...
“For scientists driving the next breakthrough in antibody or cell therapy, speed is crucial, and no instrument can rival the speed of the iQue ® HTS Platform,” says Jonah Riddell, Product Manager of ...
Molecular glues are enjoying the spotlight, but discovering new ones is often a matter of luck. A new method, developed by ...
A groundbreaking study has successfully translated high-field nuclear magnetic resonance (NMR) spectroscopy-based lipoprotein analysis into "low-cost" and easy-to-use benchtop NMR systems, enabling ...
Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discoveryEnables primary screening with high-resolution bindingFirst order ...
Molecular glues offer transformative solutions for complex diseases, targeting previously “undruggable” proteins. Key opportunities include their application in oncology, CNS disorders, and precision ...
From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: A new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results